Home/Filings/4/0001179110-10-015433
4//SEC Filing

Yates Jeffrey 4

Accession 0001179110-10-015433

CIK 0000896264other

Filed

Oct 31, 8:00 PM ET

Accepted

Nov 1, 6:58 PM ET

Size

8.7 KB

Accession

0001179110-10-015433

Insider Transaction Report

Form 4
Period: 2010-10-28
Yates Jeffrey
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2010-10-28$26.06/sh+12,430$323,92612,430 total
  • Exercise/Conversion

    Stock-Settled Stock Appreciation Rights

    2010-10-2830,00045,000 total
    Exercise: $26.06From: 2009-07-21Exp: 2014-01-21Common Stock (30,000 underlying)
  • Sale

    Common Stock

    2010-10-28$44.81/sh12,430$556,9880 total
Footnotes (2)
  • [F1]The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights desclosed in Table II.
  • [F2]Weighted Average Price. Price Range was $44.55 to $44.98.

Issuer

USANA HEALTH SCIENCES INC

CIK 0000896264

Entity typeother

Related Parties

1
  • filerCIK 0001444314

Filing Metadata

Form type
4
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 6:58 PM ET
Size
8.7 KB